Shield Therapeutics

Disc Medicine

This biopharmaceutical company develops novel therapeutic candidates to treat patients suffering from serious haematologic diseases by targeting red blood cell biology and iron homeostasis.

Portola Pharmaceuticals

This biopharmaceutical company develops and commercialises therapies for thrombosis and other haematologic conditions for healthcare providers and patients with limited treatment options.

Forma Therapeutics

This company develops medicines for patients with sickle cell disease and rare blood disorders.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Iterum Therapeutics

This pharmaceutical company develops and commercialises oral and intravenous antibiotics for patients with multi-drug resistant infections, including urinary tract infections.

Global Blood Therapeutics

This biopharmaceutical company develops and manufactures oral medicines to treat sickle cell disease for patients and healthcare providers.

Intercept Pharmaceuticals

This company develops and commercialises small molecule therapeutics to treat chronic liver diseases for healthcare providers and patients.

Esperion Therapeutics Inc

This company develops and commercialises oral cholesterol-lowering medicines for patients with hyperlipidaemia or at risk of cardiovascular disease.